Cardiovascular Disease and COVID-19: Les Liaisons Dangereuses

Overview

Journal Eur J Prev Cardiol

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2020 May 12

PMID 32391719

Citations 14

Authors

Andrea Barison

Alberto Aimo

Vincenzo Castiglione

Chiara Arzilli

Josep Lupon

Pau Codina

Evelyn Santiago-Vacas

German Cediel

Michele Emdin

Antoni Bayes-Genis

Affiliations

Soon will be listed here.

Abstract

Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.

Citing Articles

Latin-American guidelines of recommendations at discharge from an acute coronary syndrome.

Ponte-Negretti C, Zaidel E, Lopez-Santi R, Munera-Echeverri A, Bryce A, Negron S Arch Cardiol Mex. 2024; 94(Supl 2):1-52.

PMID: 38848096 PMC: 11798419. DOI: 10.24875/ACM.M24000096.

Digital health for remote home monitoring of patients with COVID-19 requiring oxygen: a cohort study and literature review.

Chaytee J, Dinh A, DAnglejan E, Bouchand F, Jaffal K, Duran C Front Med (Lausanne). 2024; 10:1255798.

PMID: 38356737 PMC: 10864516. DOI: 10.3389/fmed.2023.1255798.

[Cardiac tele-rehabilitation in times of pandemic. Experience at the National Cardiovascular Institute INCOR in Lima-Peru].

Espinoza Perez J, Coronado R, Olortegui Yzu A, Fernandez Coronado J, Vilchez Y, Heredia Nahui M Arch Peru Cardiol Cir Cardiovasc. 2023; 4(1):13-20.

PMID: 37408780 PMC: 10318993. DOI: 10.47487/apcyccv.v4i1.281.

Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation.

Ceccarini G, Gilio D, Magno S, Pelosini C, Leverone M, Miceli C J Endocrinol Invest. 2022; 45(8):1569-1575.

PMID: 35384599 PMC: 8984660. DOI: 10.1007/s40618-022-01795-6.

Post-COVID-19 Pulmonary Fibrosis.

Mohammadi A, Balan I, Yadav S, Matos W, Kharawala A, Gaddam M Cureus. 2022; 14(3):e22770.

PMID: 35371880 PMC: 8974316. DOI: 10.7759/cureus.22770.

References

Makris D, Manoulakas E, Komnos A, Papakrivou E, Tzovaras N, Hovas A . Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study. Crit Care Med. 2011; 39(11):2440-6. DOI: 10.1097/CCM.0b013e318225742c. View

Caldeira D, Alarcao J, Vaz-Carneiro A, Costa J . Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012; 345:e4260. PMC: 3394697. DOI: 10.1136/bmj.e4260. View

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

Kwong J, Li P, Redelmeier D . Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS One. 2009; 4(11):e8087. PMC: 2778952. DOI: 10.1371/journal.pone.0008087. View

Raj V, Mou H, Smits S, Dekkers D, Muller M, Dijkman R . Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495(7440):251-4. PMC: 7095326. DOI: 10.1038/nature12005. View

Fedson D . Treating influenza with statins and other immunomodulatory agents. Antiviral Res. 2013; 99(3):417-35. DOI: 10.1016/j.antiviral.2013.06.018. View

Papazian L, Roch A, Charles P, Penot-Ragon C, Perrin G, Roulier P . Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA. 2013; 310(16):1692-700. DOI: 10.1001/jama.2013.280031. View

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B . A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11(8):875-9. PMC: 7095783. DOI: 10.1038/nm1267. View

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-481. PMC: 7102538. DOI: 10.1016/S2213-2600(20)30079-5. View

10.

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

11.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

12.

Tan W, Liao W, Zhou S, Mei D, Wong W . Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2017; 40:9-17. DOI: 10.1016/j.coph.2017.12.002. View

13.

Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga A, White H . Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia. Proc (Bayl Univ Med Cent). 2019; 31(4):419-423. PMC: 6414001. DOI: 10.1080/08998280.2018.1499293. View

14.

Akhmerov A, Marban E . COVID-19 and the Heart. Circ Res. 2020; 126(10):1443-1455. DOI: 10.1161/CIRCRESAHA.120.317055. View

15.

Frost F, Petersen H, Tollestrup K, Skipper B . Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007; 131(4):1006-12. DOI: 10.1378/chest.06-1997. View

16.

Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View

17.

Falk E, Shah P, Fuster V . Coronary plaque disruption. Circulation. 1995; 92(3):657-71. DOI: 10.1161/01.cir.92.3.657. View

18.

Hemnes A, Rathinasabapathy A, Austin E, Brittain E, Carrier E, Chen X . A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J. 2018; 51(6). PMC: 6613216. DOI: 10.1183/13993003.02638-2017. View

19.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

20.

Douglas I, Evans S, Smeeth L . Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ. 2011; 342:d1642. PMC: 3071610. DOI: 10.1136/bmj.d1642. View